HEADER HYDROLASE 20-DEC-12 4IIS TITLE CRYSTAL STRUCTURE OF A GLYCOSYLATED BETA-1,3-GLUCANASE (HEV B 2), AN TITLE 2 ALLERGEN FROM HEVEA BRASILIENSIS (SPACE GROUP P41) COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA-1,3-GLUCANASE FORM 'RRII GLN 2'; COMPND 3 CHAIN: A, B, C, D; COMPND 4 EC: 3.2.1.39 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HEVEA BRASILIENSIS; SOURCE 3 ORGANISM_COMMON: PARA RUBBER TREE,JEBE,RUBBERTREE,SIRINGA; SOURCE 4 ORGANISM_TAXID: 3981; SOURCE 5 STRAIN: GV-42 KEYWDS ALLERGEN, GLYCOPROTEIN, GLYCOSIDE HYDROLASE, GH17 FAMILY, KEYWDS 2 PATHOGENESIS-RELATED CLASS-2 PROTEIN, TIM-BARREL, GLYCOSIDASE, KEYWDS 3 CARBOHYDRATE/SUGAR BINDING, PIROGLUTAMATE (N-TERMINAL RESIDUE), KEYWDS 4 LATEX, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR A.RODRIGUEZ-ROMERO,A.HERNANDEZ-SANTOYO REVDAT 5 20-SEP-23 4IIS 1 HETSYN REVDAT 4 29-JUL-20 4IIS 1 COMPND REMARK HETNAM LINK REVDAT 4 2 1 SITE ATOM REVDAT 3 25-DEC-19 4IIS 1 SEQRES LINK REVDAT 2 19-MAR-14 4IIS 1 JRNL REVDAT 1 27-NOV-13 4IIS 0 SPRSDE 27-NOV-13 4IIS 3F55 JRNL AUTH A.RODRIGUEZ-ROMERO,A.HERNANDEZ-SANTOYO,D.FUENTES-SILVA, JRNL AUTH 2 L.A.PALOMARES,S.MUNOZ-CRUZ,L.YEPEZ-MULIA,S.OROZCO-MARTINEZ JRNL TITL STRUCTURAL ANALYSIS OF THE ENDOGENOUS GLYCOALLERGEN HEV B 2 JRNL TITL 2 (ENDO-BETA-1,3-GLUCANASE) FROM HEVEA BRASILIENSIS AND ITS JRNL TITL 3 RECOGNITION BY HUMAN BASOPHILS. JRNL REF ACTA CRYSTALLOGR.,SECT.D V. 70 329 2014 JRNL REFN ISSN 0907-4449 JRNL PMID 24531467 JRNL DOI 10.1107/S1399004713027673 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH D.FUENTES-SILVA,G.MENDOZA-HERNANDEZ,V.STOJANOFF, REMARK 1 AUTH 2 L.A.PALOMARES,E.ZENTENO,A.TORRES-LARIOS,A.RODRIGUEZ-ROMERO REMARK 1 TITL CRYSTALLIZATION AND IDENTIFICATION OF THE GLYCOSYLATED REMARK 1 TITL 2 MOIETIES OF TWO ISOFORMS OF THE MAIN ALLERGEN HEV B 2 AND REMARK 1 TITL 3 PRELIMINARY X-RAY ANALYSIS OF TWO POLYMORPHS OF ISOFORM II. REMARK 1 REF ACTA CRYSTALLOGR.,SECT.F V. 63 787 2007 REMARK 1 REFN ESSN 1744-3091 REMARK 1 PMID 17768356 REMARK 1 DOI 10.1107/S1744309107039838 REMARK 2 REMARK 2 RESOLUTION. 2.67 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: DEV_1238) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : TWIN_LSQ_F REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.67 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.47 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 93.5 REMARK 3 NUMBER OF REFLECTIONS : 46257 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.202 REMARK 3 R VALUE (WORKING SET) : 0.202 REMARK 3 FREE R VALUE : 0.220 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.080 REMARK 3 FREE R VALUE TEST SET COUNT : 2352 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 33.7661 - 6.8411 0.87 2614 107 0.1528 0.1485 REMARK 3 2 6.8411 - 5.4373 0.87 2563 133 0.1928 0.1823 REMARK 3 3 5.4373 - 4.7522 0.87 2529 161 0.1589 0.1641 REMARK 3 4 4.7522 - 4.3186 0.89 2573 115 0.1523 0.1772 REMARK 3 5 4.3186 - 4.0096 0.88 2558 142 0.1572 0.1840 REMARK 3 6 4.0096 - 3.7735 0.88 2554 150 0.1782 0.1900 REMARK 3 7 3.7735 - 3.5848 0.89 2561 139 0.1809 0.2118 REMARK 3 8 3.5848 - 3.4289 0.89 2583 141 0.2104 0.2432 REMARK 3 9 3.4289 - 3.2970 0.89 2601 138 0.2140 0.2581 REMARK 3 10 3.2970 - 3.1833 0.89 2538 126 0.2308 0.2362 REMARK 3 11 3.1833 - 3.0839 0.90 2609 146 0.2481 0.2975 REMARK 3 12 3.0839 - 2.9958 0.90 2608 124 0.2635 0.2787 REMARK 3 13 2.9958 - 2.9169 0.89 2582 145 0.2748 0.2544 REMARK 3 14 2.9169 - 2.8458 0.90 2588 138 0.2938 0.3481 REMARK 3 15 2.8458 - 2.7811 0.91 2617 130 0.2984 0.2904 REMARK 3 16 2.7811 - 2.7220 0.90 2563 139 0.3183 0.3612 REMARK 3 17 2.7220 - 2.6676 0.90 2599 161 0.3466 0.4127 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.940 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 58.37 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 54.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: 0.5000 REMARK 3 OPERATOR: H,-K,-L REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.011 10217 REMARK 3 ANGLE : 1.636 13922 REMARK 3 CHIRALITY : 0.074 1518 REMARK 3 PLANARITY : 0.011 1814 REMARK 3 DIHEDRAL : 13.546 3740 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4IIS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-JAN-13. REMARK 100 THE DEPOSITION ID IS D_1000076804. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-MAR-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X6A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.977 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 49364 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.610 REMARK 200 RESOLUTION RANGE LOW (A) : 47.473 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.1 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.08900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.61 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.76 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.60 REMARK 200 R MERGE FOR SHELL (I) : 0.62900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 4HPG REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 60.11 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.08 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M TRISODIUM CITRATE DIHYDRATE, 0.1M REMARK 280 SODIUM CACODYLATE, 30% (W/V) 2-PROPANOL, PH 6.5, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+1/4 REMARK 290 4555 Y,-X,Z+3/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 38.66550 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 19.33275 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 57.99825 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASN A 11 CG OD1 ND2 REMARK 470 ASN A 12 CG OD1 ND2 REMARK 470 GLU A 18 CG CD OE1 OE2 REMARK 470 ARG A 85 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 188 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 276 CG CD CE NZ REMARK 470 ASN A 306 CG OD1 ND2 REMARK 470 ASN A 312 CG OD1 ND2 REMARK 470 TRP B 81 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP B 81 CZ3 CH2 REMARK 470 GLN B 107 CG CD OE1 NE2 REMARK 470 ARG B 164 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 170 CG CD NE CZ NH1 NH2 REMARK 470 TRP C 81 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP C 81 CZ3 CH2 REMARK 470 LYS C 130 CG CD CE NZ REMARK 470 ARG C 209 CG CD NE CZ NH1 NH2 REMARK 470 ASP C 254 CG OD1 OD2 REMARK 470 ARG C 269 CG CD NE CZ NH1 NH2 REMARK 470 LYS C 291 CG CD CE NZ REMARK 470 ARG D 85 CG CD NE CZ NH1 NH2 REMARK 470 ARG D 269 CG CD NE CZ NH1 NH2 REMARK 470 LYS D 276 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TRP A 104 3.80 -66.49 REMARK 500 ASN A 312 66.18 61.76 REMARK 500 TRP B 104 4.22 -66.84 REMARK 500 ASN B 312 66.57 62.92 REMARK 500 TRP C 104 3.04 -68.16 REMARK 500 ASN C 312 65.49 61.95 REMARK 500 TRP D 104 2.85 -68.16 REMARK 500 ASN D 312 66.62 62.31 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4HPG RELATED DB: PDB REMARK 900 THE SAME PROTEIN CRYSTALLIZED IN SPACE GROUP P21 (POLYMORPH) DBREF 4IIS A 1 316 UNP D1M8S7 D1M8S7_HEVBR 37 352 DBREF 4IIS B 1 316 UNP D1M8S7 D1M8S7_HEVBR 37 352 DBREF 4IIS C 1 316 UNP D1M8S7 D1M8S7_HEVBR 37 352 DBREF 4IIS D 1 316 UNP D1M8S7 D1M8S7_HEVBR 37 352 SEQRES 1 A 316 PCA VAL GLY VAL CYS TYR GLY MET GLN GLY ASN ASN LEU SEQRES 2 A 316 PRO PRO VAL SER GLU VAL ILE ALA LEU TYR LYS LYS SER SEQRES 3 A 316 ASN ILE THR ARG MET ARG ILE TYR ASP PRO ASN GLN ALA SEQRES 4 A 316 VAL LEU GLU ALA LEU ARG GLY SER ASN ILE GLU LEU ILE SEQRES 5 A 316 LEU GLY VAL PRO ASN SER ASP LEU GLN SER LEU THR ASN SEQRES 6 A 316 PRO SER ASN ALA LYS SER TRP VAL GLN LYS ASN VAL ARG SEQRES 7 A 316 GLY PHE TRP SER SER VAL ARG PHE ARG TYR ILE ALA VAL SEQRES 8 A 316 GLY ASN GLU ILE SER PRO VAL ASN ARG GLY THR ALA TRP SEQRES 9 A 316 LEU ALA GLN PHE VAL LEU PRO ALA MET ARG ASN ILE HIS SEQRES 10 A 316 ASP ALA ILE ARG SER ALA GLY LEU GLN ASP GLN ILE LYS SEQRES 11 A 316 VAL SER THR ALA ILE ASP LEU THR LEU VAL GLY ASN SER SEQRES 12 A 316 TYR PRO PRO SER ALA GLY ALA PHE ARG ASP ASP VAL ARG SEQRES 13 A 316 SER TYR LEU ASN PRO ILE ILE ARG PHE LEU SER SER ILE SEQRES 14 A 316 ARG SER PRO LEU LEU ALA ASN ILE TYR PRO TYR PHE THR SEQRES 15 A 316 TYR ALA GLY ASN PRO ARG ASP ILE SER LEU PRO TYR ALA SEQRES 16 A 316 LEU PHE THR SER PRO SER VAL VAL VAL TRP ASP GLY GLN SEQRES 17 A 316 ARG GLY TYR LYS ASN LEU PHE ASP ALA THR LEU ASP ALA SEQRES 18 A 316 LEU TYR SER ALA LEU GLU ARG ALA SER GLY GLY SER LEU SEQRES 19 A 316 GLU VAL VAL VAL SER GLU SER GLY TRP PRO SER ALA GLY SEQRES 20 A 316 ALA PHE ALA ALA THR PHE ASP ASN GLY ARG THR TYR LEU SEQRES 21 A 316 SER ASN LEU ILE GLN HIS VAL LYS ARG GLY THR PRO LYS SEQRES 22 A 316 ARG PRO LYS ARG ALA ILE GLU THR TYR LEU PHE ALA MET SEQRES 23 A 316 PHE ASP GLU ASN LYS LYS GLN PRO GLU VAL GLU LYS HIS SEQRES 24 A 316 PHE GLY LEU PHE PHE PRO ASN LYS TRP GLN LYS TYR ASN SEQRES 25 A 316 LEU ASN PHE SER SEQRES 1 B 316 PCA VAL GLY VAL CYS TYR GLY MET GLN GLY ASN ASN LEU SEQRES 2 B 316 PRO PRO VAL SER GLU VAL ILE ALA LEU TYR LYS LYS SER SEQRES 3 B 316 ASN ILE THR ARG MET ARG ILE TYR ASP PRO ASN GLN ALA SEQRES 4 B 316 VAL LEU GLU ALA LEU ARG GLY SER ASN ILE GLU LEU ILE SEQRES 5 B 316 LEU GLY VAL PRO ASN SER ASP LEU GLN SER LEU THR ASN SEQRES 6 B 316 PRO SER ASN ALA LYS SER TRP VAL GLN LYS ASN VAL ARG SEQRES 7 B 316 GLY PHE TRP SER SER VAL ARG PHE ARG TYR ILE ALA VAL SEQRES 8 B 316 GLY ASN GLU ILE SER PRO VAL ASN ARG GLY THR ALA TRP SEQRES 9 B 316 LEU ALA GLN PHE VAL LEU PRO ALA MET ARG ASN ILE HIS SEQRES 10 B 316 ASP ALA ILE ARG SER ALA GLY LEU GLN ASP GLN ILE LYS SEQRES 11 B 316 VAL SER THR ALA ILE ASP LEU THR LEU VAL GLY ASN SER SEQRES 12 B 316 TYR PRO PRO SER ALA GLY ALA PHE ARG ASP ASP VAL ARG SEQRES 13 B 316 SER TYR LEU ASN PRO ILE ILE ARG PHE LEU SER SER ILE SEQRES 14 B 316 ARG SER PRO LEU LEU ALA ASN ILE TYR PRO TYR PHE THR SEQRES 15 B 316 TYR ALA GLY ASN PRO ARG ASP ILE SER LEU PRO TYR ALA SEQRES 16 B 316 LEU PHE THR SER PRO SER VAL VAL VAL TRP ASP GLY GLN SEQRES 17 B 316 ARG GLY TYR LYS ASN LEU PHE ASP ALA THR LEU ASP ALA SEQRES 18 B 316 LEU TYR SER ALA LEU GLU ARG ALA SER GLY GLY SER LEU SEQRES 19 B 316 GLU VAL VAL VAL SER GLU SER GLY TRP PRO SER ALA GLY SEQRES 20 B 316 ALA PHE ALA ALA THR PHE ASP ASN GLY ARG THR TYR LEU SEQRES 21 B 316 SER ASN LEU ILE GLN HIS VAL LYS ARG GLY THR PRO LYS SEQRES 22 B 316 ARG PRO LYS ARG ALA ILE GLU THR TYR LEU PHE ALA MET SEQRES 23 B 316 PHE ASP GLU ASN LYS LYS GLN PRO GLU VAL GLU LYS HIS SEQRES 24 B 316 PHE GLY LEU PHE PHE PRO ASN LYS TRP GLN LYS TYR ASN SEQRES 25 B 316 LEU ASN PHE SER SEQRES 1 C 316 PCA VAL GLY VAL CYS TYR GLY MET GLN GLY ASN ASN LEU SEQRES 2 C 316 PRO PRO VAL SER GLU VAL ILE ALA LEU TYR LYS LYS SER SEQRES 3 C 316 ASN ILE THR ARG MET ARG ILE TYR ASP PRO ASN GLN ALA SEQRES 4 C 316 VAL LEU GLU ALA LEU ARG GLY SER ASN ILE GLU LEU ILE SEQRES 5 C 316 LEU GLY VAL PRO ASN SER ASP LEU GLN SER LEU THR ASN SEQRES 6 C 316 PRO SER ASN ALA LYS SER TRP VAL GLN LYS ASN VAL ARG SEQRES 7 C 316 GLY PHE TRP SER SER VAL ARG PHE ARG TYR ILE ALA VAL SEQRES 8 C 316 GLY ASN GLU ILE SER PRO VAL ASN ARG GLY THR ALA TRP SEQRES 9 C 316 LEU ALA GLN PHE VAL LEU PRO ALA MET ARG ASN ILE HIS SEQRES 10 C 316 ASP ALA ILE ARG SER ALA GLY LEU GLN ASP GLN ILE LYS SEQRES 11 C 316 VAL SER THR ALA ILE ASP LEU THR LEU VAL GLY ASN SER SEQRES 12 C 316 TYR PRO PRO SER ALA GLY ALA PHE ARG ASP ASP VAL ARG SEQRES 13 C 316 SER TYR LEU ASN PRO ILE ILE ARG PHE LEU SER SER ILE SEQRES 14 C 316 ARG SER PRO LEU LEU ALA ASN ILE TYR PRO TYR PHE THR SEQRES 15 C 316 TYR ALA GLY ASN PRO ARG ASP ILE SER LEU PRO TYR ALA SEQRES 16 C 316 LEU PHE THR SER PRO SER VAL VAL VAL TRP ASP GLY GLN SEQRES 17 C 316 ARG GLY TYR LYS ASN LEU PHE ASP ALA THR LEU ASP ALA SEQRES 18 C 316 LEU TYR SER ALA LEU GLU ARG ALA SER GLY GLY SER LEU SEQRES 19 C 316 GLU VAL VAL VAL SER GLU SER GLY TRP PRO SER ALA GLY SEQRES 20 C 316 ALA PHE ALA ALA THR PHE ASP ASN GLY ARG THR TYR LEU SEQRES 21 C 316 SER ASN LEU ILE GLN HIS VAL LYS ARG GLY THR PRO LYS SEQRES 22 C 316 ARG PRO LYS ARG ALA ILE GLU THR TYR LEU PHE ALA MET SEQRES 23 C 316 PHE ASP GLU ASN LYS LYS GLN PRO GLU VAL GLU LYS HIS SEQRES 24 C 316 PHE GLY LEU PHE PHE PRO ASN LYS TRP GLN LYS TYR ASN SEQRES 25 C 316 LEU ASN PHE SER SEQRES 1 D 316 PCA VAL GLY VAL CYS TYR GLY MET GLN GLY ASN ASN LEU SEQRES 2 D 316 PRO PRO VAL SER GLU VAL ILE ALA LEU TYR LYS LYS SER SEQRES 3 D 316 ASN ILE THR ARG MET ARG ILE TYR ASP PRO ASN GLN ALA SEQRES 4 D 316 VAL LEU GLU ALA LEU ARG GLY SER ASN ILE GLU LEU ILE SEQRES 5 D 316 LEU GLY VAL PRO ASN SER ASP LEU GLN SER LEU THR ASN SEQRES 6 D 316 PRO SER ASN ALA LYS SER TRP VAL GLN LYS ASN VAL ARG SEQRES 7 D 316 GLY PHE TRP SER SER VAL ARG PHE ARG TYR ILE ALA VAL SEQRES 8 D 316 GLY ASN GLU ILE SER PRO VAL ASN ARG GLY THR ALA TRP SEQRES 9 D 316 LEU ALA GLN PHE VAL LEU PRO ALA MET ARG ASN ILE HIS SEQRES 10 D 316 ASP ALA ILE ARG SER ALA GLY LEU GLN ASP GLN ILE LYS SEQRES 11 D 316 VAL SER THR ALA ILE ASP LEU THR LEU VAL GLY ASN SER SEQRES 12 D 316 TYR PRO PRO SER ALA GLY ALA PHE ARG ASP ASP VAL ARG SEQRES 13 D 316 SER TYR LEU ASN PRO ILE ILE ARG PHE LEU SER SER ILE SEQRES 14 D 316 ARG SER PRO LEU LEU ALA ASN ILE TYR PRO TYR PHE THR SEQRES 15 D 316 TYR ALA GLY ASN PRO ARG ASP ILE SER LEU PRO TYR ALA SEQRES 16 D 316 LEU PHE THR SER PRO SER VAL VAL VAL TRP ASP GLY GLN SEQRES 17 D 316 ARG GLY TYR LYS ASN LEU PHE ASP ALA THR LEU ASP ALA SEQRES 18 D 316 LEU TYR SER ALA LEU GLU ARG ALA SER GLY GLY SER LEU SEQRES 19 D 316 GLU VAL VAL VAL SER GLU SER GLY TRP PRO SER ALA GLY SEQRES 20 D 316 ALA PHE ALA ALA THR PHE ASP ASN GLY ARG THR TYR LEU SEQRES 21 D 316 SER ASN LEU ILE GLN HIS VAL LYS ARG GLY THR PRO LYS SEQRES 22 D 316 ARG PRO LYS ARG ALA ILE GLU THR TYR LEU PHE ALA MET SEQRES 23 D 316 PHE ASP GLU ASN LYS LYS GLN PRO GLU VAL GLU LYS HIS SEQRES 24 D 316 PHE GLY LEU PHE PHE PRO ASN LYS TRP GLN LYS TYR ASN SEQRES 25 D 316 LEU ASN PHE SER MODRES 4IIS ASN C 27 ASN GLYCOSYLATION SITE MODRES 4IIS PCA A 1 GLN PYROGLUTAMIC ACID MODRES 4IIS PCA B 1 GLN PYROGLUTAMIC ACID MODRES 4IIS PCA C 1 GLN PYROGLUTAMIC ACID MODRES 4IIS PCA D 1 GLN PYROGLUTAMIC ACID HET PCA A 1 8 HET PCA B 1 8 HET PCA C 1 8 HET PCA D 1 8 HET NAG E 1 14 HET NAG E 2 14 HET FLC A 401 13 HET FLC A 402 13 HET CAC A 403 5 HET NA C 403 1 HET FLC D 401 13 HETNAM PCA PYROGLUTAMIC ACID HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM FLC CITRATE ANION HETNAM CAC CACODYLATE ION HETNAM NA SODIUM ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN CAC DIMETHYLARSINATE FORMUL 1 PCA 4(C5 H7 N O3) FORMUL 5 NAG 2(C8 H15 N O6) FORMUL 6 FLC 3(C6 H5 O7 3-) FORMUL 8 CAC C2 H6 AS O2 1- FORMUL 9 NA NA 1+ FORMUL 11 HOH *56(H2 O) HELIX 1 1 PRO A 15 SER A 26 1 12 HELIX 2 2 ASN A 37 LEU A 44 1 8 HELIX 3 3 PRO A 56 GLN A 61 1 6 HELIX 4 4 SER A 62 THR A 64 5 3 HELIX 5 5 ASN A 65 VAL A 77 1 13 HELIX 6 6 THR A 102 GLN A 107 5 6 HELIX 7 7 PHE A 108 ALA A 123 1 16 HELIX 8 8 ASP A 136 THR A 138 5 3 HELIX 9 9 PRO A 145 GLY A 149 5 5 HELIX 10 10 VAL A 155 ILE A 169 1 15 HELIX 11 11 TYR A 178 ASN A 186 1 9 HELIX 12 12 SER A 191 PHE A 197 1 7 HELIX 13 13 ASN A 213 ALA A 229 1 17 HELIX 14 14 THR A 252 VAL A 267 1 16 HELIX 15 15 PRO A 294 HIS A 299 5 6 HELIX 16 16 PRO B 15 SER B 26 1 12 HELIX 17 17 ASN B 37 LEU B 44 1 8 HELIX 18 18 PRO B 56 LEU B 60 5 5 HELIX 19 19 GLN B 61 THR B 64 5 4 HELIX 20 20 ASN B 65 VAL B 77 1 13 HELIX 21 21 THR B 102 GLN B 107 5 6 HELIX 22 22 PHE B 108 ALA B 123 1 16 HELIX 23 23 ASP B 136 THR B 138 5 3 HELIX 24 24 PRO B 145 GLY B 149 5 5 HELIX 25 25 VAL B 155 ILE B 169 1 15 HELIX 26 26 TYR B 178 ASN B 186 1 9 HELIX 27 27 SER B 191 PHE B 197 1 7 HELIX 28 28 ASN B 213 ALA B 229 1 17 HELIX 29 29 THR B 252 VAL B 267 1 16 HELIX 30 30 PRO B 294 HIS B 299 5 6 HELIX 31 31 PRO C 15 SER C 26 1 12 HELIX 32 32 ASN C 37 LEU C 44 1 8 HELIX 33 33 PRO C 56 SER C 58 5 3 HELIX 34 34 ASP C 59 THR C 64 1 6 HELIX 35 35 ASN C 65 VAL C 77 1 13 HELIX 36 36 THR C 102 GLN C 107 5 6 HELIX 37 37 PHE C 108 GLY C 124 1 17 HELIX 38 38 ASP C 136 THR C 138 5 3 HELIX 39 39 PRO C 145 GLY C 149 5 5 HELIX 40 40 VAL C 155 ARG C 170 1 16 HELIX 41 41 TYR C 178 ASN C 186 1 9 HELIX 42 42 SER C 191 LEU C 196 1 6 HELIX 43 43 ASN C 213 ALA C 229 1 17 HELIX 44 44 THR C 252 VAL C 267 1 16 HELIX 45 45 PRO C 294 HIS C 299 5 6 HELIX 46 46 PRO D 15 ASN D 27 1 13 HELIX 47 47 ASN D 37 LEU D 44 1 8 HELIX 48 48 PRO D 56 LEU D 60 5 5 HELIX 49 49 GLN D 61 THR D 64 5 4 HELIX 50 50 ASN D 65 VAL D 77 1 13 HELIX 51 51 THR D 102 TRP D 104 5 3 HELIX 52 52 LEU D 105 ALA D 123 1 19 HELIX 53 53 ASP D 136 THR D 138 5 3 HELIX 54 54 PRO D 145 GLY D 149 5 5 HELIX 55 55 VAL D 155 ILE D 169 1 15 HELIX 56 56 TYR D 178 ASN D 186 1 9 HELIX 57 57 SER D 191 PHE D 197 1 7 HELIX 58 58 ASN D 213 ALA D 229 1 17 HELIX 59 59 THR D 252 VAL D 267 1 16 HELIX 60 60 PRO D 294 HIS D 299 5 6 SHEET 1 A 8 VAL A 236 GLU A 240 0 SHEET 2 A 8 LEU A 173 ASN A 176 1 N ALA A 175 O VAL A 237 SHEET 3 A 8 LYS A 130 ILE A 135 1 N ILE A 135 O ASN A 176 SHEET 4 A 8 PHE A 86 ASN A 93 1 N VAL A 91 O SER A 132 SHEET 5 A 8 GLU A 50 VAL A 55 1 N LEU A 51 O ARG A 87 SHEET 6 A 8 ARG A 30 ARG A 32 1 N MET A 31 O ILE A 52 SHEET 7 A 8 GLY A 3 CYS A 5 1 N VAL A 4 O ARG A 30 SHEET 8 A 8 TYR A 282 LEU A 283 1 O LEU A 283 N GLY A 3 SHEET 1 B 2 VAL A 140 ASN A 142 0 SHEET 2 B 2 ALA A 150 PHE A 151 -1 O ALA A 150 N ASN A 142 SHEET 1 C 2 VAL A 204 ASP A 206 0 SHEET 2 C 2 ARG A 209 TYR A 211 -1 O TYR A 211 N VAL A 204 SHEET 1 D 8 VAL B 236 GLU B 240 0 SHEET 2 D 8 LEU B 173 ASN B 176 1 N ALA B 175 O VAL B 237 SHEET 3 D 8 LYS B 130 ILE B 135 1 N ILE B 135 O ASN B 176 SHEET 4 D 8 ARG B 85 ASN B 93 1 N VAL B 91 O SER B 132 SHEET 5 D 8 GLU B 50 VAL B 55 1 N LEU B 51 O ARG B 85 SHEET 6 D 8 ARG B 30 ILE B 33 1 N MET B 31 O ILE B 52 SHEET 7 D 8 GLY B 3 TYR B 6 1 N TYR B 6 O ARG B 32 SHEET 8 D 8 TYR B 282 LEU B 283 1 O LEU B 283 N CYS B 5 SHEET 1 E 2 VAL B 140 ASN B 142 0 SHEET 2 E 2 ALA B 150 PHE B 151 -1 O ALA B 150 N GLY B 141 SHEET 1 F 2 VAL B 204 ASP B 206 0 SHEET 2 F 2 ARG B 209 TYR B 211 -1 O TYR B 211 N VAL B 204 SHEET 1 G 9 GLY C 3 CYS C 5 0 SHEET 2 G 9 ARG C 30 ARG C 32 1 O ARG C 30 N VAL C 4 SHEET 3 G 9 GLU C 50 VAL C 55 1 O GLU C 50 N MET C 31 SHEET 4 G 9 ARG C 85 ASN C 93 1 O ARG C 87 N LEU C 51 SHEET 5 G 9 LYS C 130 ILE C 135 1 O SER C 132 N VAL C 91 SHEET 6 G 9 LEU C 173 ASN C 176 1 O ASN C 176 N ILE C 135 SHEET 7 G 9 VAL C 236 SER C 241 1 O VAL C 237 N LEU C 173 SHEET 8 G 9 THR C 281 LEU C 283 1 O TYR C 282 N VAL C 238 SHEET 9 G 9 GLY C 3 CYS C 5 1 N CYS C 5 O LEU C 283 SHEET 1 H 2 VAL C 140 ASN C 142 0 SHEET 2 H 2 ALA C 150 PHE C 151 -1 O ALA C 150 N ASN C 142 SHEET 1 I 2 VAL C 204 ASP C 206 0 SHEET 2 I 2 ARG C 209 TYR C 211 -1 O ARG C 209 N ASP C 206 SHEET 1 J 9 GLY D 3 CYS D 5 0 SHEET 2 J 9 ARG D 30 ILE D 33 1 O ARG D 30 N VAL D 4 SHEET 3 J 9 GLU D 50 VAL D 55 1 O ILE D 52 N MET D 31 SHEET 4 J 9 PHE D 86 ASN D 93 1 O TYR D 88 N LEU D 53 SHEET 5 J 9 LYS D 130 ILE D 135 1 O SER D 132 N VAL D 91 SHEET 6 J 9 LEU D 173 ASN D 176 1 O ASN D 176 N ILE D 135 SHEET 7 J 9 VAL D 236 SER D 241 1 O VAL D 237 N LEU D 173 SHEET 8 J 9 THR D 281 LEU D 283 1 O TYR D 282 N VAL D 238 SHEET 9 J 9 GLY D 3 CYS D 5 1 N CYS D 5 O LEU D 283 SHEET 1 K 2 VAL D 140 ASN D 142 0 SHEET 2 K 2 ALA D 150 PHE D 151 -1 O ALA D 150 N ASN D 142 SHEET 1 L 2 VAL D 204 ASP D 206 0 SHEET 2 L 2 ARG D 209 TYR D 211 -1 O TYR D 211 N VAL D 204 LINK C PCA A 1 N VAL A 2 1555 1555 1.32 LINK C PCA B 1 N VAL B 2 1555 1555 1.33 LINK C PCA C 1 N VAL C 2 1555 1555 1.32 LINK ND2 ASN C 27 C1 NAG E 1 1555 1555 1.47 LINK C PCA D 1 N VAL D 2 1555 1555 1.33 LINK O4 NAG E 1 C1 NAG E 2 1555 1555 1.47 CISPEP 1 TYR A 144 PRO A 145 0 -2.18 CISPEP 2 PHE A 284 ALA A 285 0 2.04 CISPEP 3 GLN A 293 PRO A 294 0 1.92 CISPEP 4 TYR B 144 PRO B 145 0 -2.55 CISPEP 5 PHE B 284 ALA B 285 0 2.56 CISPEP 6 GLN B 293 PRO B 294 0 -0.41 CISPEP 7 TYR C 144 PRO C 145 0 -2.69 CISPEP 8 PHE C 284 ALA C 285 0 1.59 CISPEP 9 GLN C 293 PRO C 294 0 1.73 CISPEP 10 TYR D 144 PRO D 145 0 -0.80 CISPEP 11 PHE D 284 ALA D 285 0 2.76 CISPEP 12 GLN D 293 PRO D 294 0 0.74 CRYST1 150.118 150.118 77.331 90.00 90.00 90.00 P 41 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006661 0.000000 0.000000 0.00000 SCALE2 0.000000 0.006661 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012931 0.00000 HETATM 1 N PCA A 1 -37.372 -3.971 11.701 1.00 57.88 N HETATM 2 CA PCA A 1 -38.526 -4.666 11.125 1.00 54.94 C HETATM 3 CB PCA A 1 -39.832 -4.240 11.787 1.00 52.57 C HETATM 4 CG PCA A 1 -39.511 -2.941 12.499 1.00 56.97 C HETATM 5 CD PCA A 1 -38.002 -2.924 12.516 1.00 56.81 C HETATM 6 OE PCA A 1 -37.382 -2.092 13.185 1.00 56.94 O HETATM 7 C PCA A 1 -38.731 -4.328 9.664 1.00 53.75 C HETATM 8 O PCA A 1 -38.474 -3.219 9.197 1.00 52.77 O